References
- Fusco BM, Giacovazzo M. Peppers and pain. The promise of capsaicin. Drugs 1997;53:909–14.
- Peppin JF, Pappagallo M. Capsaicinoids in the treatment of neuropathic pain. Adv Neurol Disord 2014;7:308–10.
- Rollyson WD, Stover CA, Brown KC, et al. Bioavailability of capsaicin and its implications for drug delivery. J Control Release 2014;196:96–105.
- Zang P, Gao W, Zhang L, et al. In vitro evaluation of topical microemulsion of capsaicin free of surfactant. Biol Pharm Bull 2008;31:2316–20.
- Peng X, Zhou Y, Han K, et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Drug Des Devel Ther 2015;9:4209–18.
- Jensen TS, Hoye K, Fricova J, et al. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study. Europ J Pain 2014;18:1240–7.
- Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. A randomized double-blind study. Lancet Neurol 2008;7:1106–2.
- Simpson DM, Brown S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008;70:2305–13.
- Guy RH. Transdermal drug delivery. In: Schafer-Korting M, ed. Handbook of experimental pharmacology 197 drug delivery. Berlin: Springer; 2004: 399–410.
- Barry B, Williams A. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–18.
- Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64:11–29.
- Ito Y, Hagiwara E, Saeki A, et al. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006a;29:82–8.
- Ito Y, Yoshimitsu J, Shiroyama K, et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 2006b;14:255–62.
- Ito Y, Murakami A, Maeda T, et al. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. Int J Pharm 2008a;349:124–9.
- Ito Y, Ohashi Y, Shiroyama K, et al. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. Biol Pharm Bull 2008b;31:1631–3.
- Ito Y, Saeki A, Shiroyama K, et al. Percutaneous absorption of interferon-alpha by self-dissolving micropiles. J Drug Target 2008c;16:243–9.
- Ito Y, Ohashi Y, Saeki A, et al. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem Pharm Bull 2008d;56:243–6.
- Ito Y, Ohta J, Imada K, et al. Dissolving microneedles to obtain rapid local anesthetic effect of lidocaine at skin tissue. J Drug Target 2013;21:770–5.
- Takada K. Microfabrication-derived DDS: from batch to individual production. Drug Discov Ther 2008e;2:140–55.
- Ito Y, Kashiwara S, Fukushima K, Takada K. Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats. Drug Dev Ind Pharm 2011;37:1387–93.
- Ito Y, Hamasaki N, Higashino H, et al. Method to increase the systemically delivered amount of drug from dissolving microneedles. Chem Pharm Bull 2013;61:8–15.
- Mason L, Moore RA, Derry S, et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. Br Med J 2004;328:991–4.
- Römgens AM, Bader DL, Bouwstra JA, Oomens Cees WJ. A theoretical compartment model for antigen kinetics in the skin. Eur J Pharm Sci 2016;84:18–25.
- Milewski M, Yerramreddy TR, Ghosh P, et al. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. J Control Release 2010;146:37–44.
- Ito Y, Nakahigashi T, Yoshimoto N, et al. Transdermal insulin application system with dissolving microneedles. Diabet Tech Ther 2012;14:891–9.
- Ito Y, Yoshimura M, Tanaka T, Takada K. Effect of lipophilicity on the bioavailability of drugs after percutaneous administration by dissolving microneedles. J Pharm Sci 2012;101:1145–56.
- Iida T, Moriyama T, Kobata K, et al. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuro Pharmacol 2003;15:958–67.
- Shiobara T, Usui T, Han J, et al. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occluding. PLoS One 2013;11:1–12.